Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Cortez-Pinto, H."" wg kryterium: Wszystkie pola


Tytuł:
A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry.
Autorzy:
Björnsson ES; Faculty of Medicine, University of Iceland, Reykjavík, Iceland.; Department of Gastroenterology, Landspitali University Hospital Reykjavik, Reykjavík, Iceland.
Stephens C; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
Atallah E; Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
Robles-Diaz M; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
Alvarez-Alvarez I; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
Gerbes A; Department of Medicine II, LMU Klinikum Munich, Munich, Germany.
Weber S; Department of Medicine II, LMU Klinikum Munich, Munich, Germany.
Stirnimann G; Department of Visceral Surgery and Medicine, Inselspital University Hospital and University of Bern, Bern, Switzerland.
Kullak-Ublick G; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Cortez-Pinto H; Clínica Universitária de Gastrenterologia, Faculdade de Medicina de Lisboa, Universidade de Lisboa, Centro Hospitalar Lisboa Norte, HSM, Lisbon, Portugal.
Grove JI; Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
Lucena MI; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
Andrade RJ; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
Aithal GP; Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2023 Jan; Vol. 43 (1), pp. 115-126. Date of Electronic Publication: 2022 Aug 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Nitrofurantoin*
Chemical and Drug Induced Liver Injury*/epidemiology
Chemical and Drug Induced Liver Injury*/etiology
Humans ; Female ; Middle Aged ; Male ; Prospective Studies ; Infliximab ; Immunomodulating Agents ; Anti-Bacterial Agents ; Registries
Czasopismo naukowe
Tytuł:
Prevalence and risk factors of fatty liver in Portuguese adults.
Autorzy:
Leitão J; Department of Internal Medicine, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Carvalhana S; Department of Gastroenterology, Centro Hospitalar e Universitário Lisboa Norte, Lisboa, Portugal.
Cochicho J; Department of Internal Medicine, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Silva AP; Department of Gastroenterology, Centro Hospitalar de Vila Nova de Gaia e Espinho, Vila Nova de Gaia, Portugal.
Velasco F; Department of Gastroenterology, Centro Hospitalar do Algarve, Hospital de Faro, Faro, Portugal.
Medeiros I; Department of Gastroenterology, Hospital Espírito Santo, Évora, Portugal.
Alves AC; Biosystems and Integrative Science Institute (BioISI), Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisboa, Portugal.
Bourbon M; Biosystems and Integrative Science Institute (BioISI), Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisboa, Portugal.
Oliveiros B; Laboratory of Biostatistics and Medical Informatics, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Rodrigues V; Instituto de Higiene e Medicina Social, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Sousa R; Centro de Estudos de Medicina Baseada na Evidência, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Sampaio F; Centro de Estudos de Medicina Baseada na Evidência, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
Carvalho A; Department of Internal Medicine, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Cortez-Pinto H; Department of Gastroenterology, Centro Hospitalar e Universitário Lisboa Norte, Lisboa, Portugal.; Clínica Universitária de Gastrenterologia, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Pokaż więcej
Źródło:
European journal of clinical investigation [Eur J Clin Invest] 2020 Jun; Vol. 50 (6), pp. e13235. Date of Electronic Publication: 2020 May 19.
Typ publikacji:
Journal Article
MeSH Terms:
Alcohol Drinking/*epidemiology
Diabetes Mellitus/*epidemiology
Fatty Liver/*epidemiology
Liver Diseases, Alcoholic/*mortality
Non-alcoholic Fatty Liver Disease/*epidemiology
Obesity/*epidemiology
Adolescent ; Adult ; Age Distribution ; Aged ; Aged, 80 and over ; Diet/statistics & numerical data ; Female ; Humans ; Logistic Models ; Male ; Metabolic Syndrome/epidemiology ; Middle Aged ; Non-alcoholic Fatty Liver Disease/mortality ; Portugal/epidemiology ; Prevalence ; Risk Factors ; Sex Distribution ; Young Adult
Czasopismo naukowe
Tytuł:
Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease
Autorzy:
Ferreira, D. M. S.
Castro, R. E.
Machado, M. V.
Evangelista, T.
Silvestre, A.
Costa, A.
Coutinho, J.
Carepa, F.
Cortez-Pinto, H.
Rodrigues, C. M. P.
Pokaż więcej
Źródło:
Diabetologia: Clinical and Experimental Diabetes and Metabolism. July 2011 54(7):1788-1798
Czasopismo naukowe
Tytuł:
The paradigm shift from NAFLD to MAFLD: A global primary care viewpoint.
Autorzy:
Farahat TM; The Egyptian Family Medicine Association (EFMA), WONCA East Mediterranean, Department of Public Health and Community Medicines, Menoufia University, Menoufia, Egypt.
Ungan M; The Turkish Association of Family Physicians (TAHUD), WONCA Europe, Department of Family Medicine, Ankara University School of Medicine, Ankara, Turkey.
Vilaseca J; Barcelona Esquerra Primary Health Care Consortium, Barcelona, Spain.; WONCA Europe, Faculty of Medicine, University of Barcelona, Barcelona, Spain.; Faculty of MedicineUniversity of Vic - Central University of Catalonia, Vic, Barcelona, Spain.
Ponzo J; WONCA Iberoamericana, Departamento de Montevideo, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
Gupta PP; WONCA South Asia, Department of General Practice and Emergency Medicine, B.P. Koirala Institute of Health Sciences, Dharan, Nepal.
Schreiner AD; Departments of Medicine Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Al Sharief W; President Emirates Family Medicine Society, President Family Medicine Scientific Council in Arab Board for Medical Specialization Council, Director Medical Education & Research Department, Dubai, UAE.
Casler K; Director of Family Nurse Practitioner Program, The Ohio State University College of Nursing, Columbus, Ohio, USA.
Abdelkader T; Algerian Society of General Medicine/Societe Algerienne De Medecine Generale (SAMG), Algeria.
Abenavoli L; Department of Health Sciences, Magna Graecia University, Catanzaro, Italy.
Alami FM; National Collective of General Practitioners of Marocco (MG Maroc), Rabat, Morocco.
Ekstedt M; Division of Diagnostics and Specialist Medicine, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Jabir MS; President of the Iraqi Family Physicians Society, Baghdad, Iraq.
Armstrong MJ; Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Osman MH; Department of Family Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Wiegand J; Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany.
Attia D; Department of Gastroenterology, Hepatology and Endemic Medicine, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
Verhoeven V; Department of FAMPOP (Family Medicine and Population Health), University of Antwerp, Antwerpen, Belgium.
Amir AAQ; International Medical Center Hospital-Jeddah, Jeddah, Saudi Arabia.
Hegazy NN; The Egyptian Family Medicine Association (EFMA), WONCA East Mediterranean, Department of Public Health and Community Medicines, Menoufia University, Menoufia, Egypt.
Tsochatzis EA; UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, UK.
Fouad Y; Department of Gastroenterology, Hepatology and Endemic Medicine, Faculty of Medicine, Minia University, Minya, Egypt.
Cortez-Pinto H; Clínica Universitária de Gastrenterologia, Laboratório de Nutrição, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2022 Jun; Vol. 42 (6), pp. 1259-1267. Date of Electronic Publication: 2022 Mar 11.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Non-alcoholic Fatty Liver Disease*
Disease Progression ; Humans ; Primary Health Care
Czasopismo naukowe
Tytuł:
Correlation of Genotypes and Route of Transmission with Histologic Activity and Disease Stage in Chronic Hepatitis C
Autorzy:
Ramalho, Fernando
Costa, Adília
Pires, Antónia
Cabrita, Paula
Serejo, Fátima
Pinto Correia, A.
Fatela, Narcisa
Clória, Helena
Lopes, Joäo
Cortez Pinto, H.
Marinho, Rui
Raimundo, Miguel
Velosa, José
Batista, Amélia
Carneiro De Moura, M.
Pokaż więcej
Źródło:
Digestive Diseases and Sciences. January 2000 45(1):182-187
Czasopismo naukowe
Tytuł:
Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C.
Autorzy:
Duffell E; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Cortez-Pinto H; Laboratório de Nutrição, Faculdade de Medicina, Clínica Universitária de Gastrenterologia, Universidade de Lisboa, Lisboa, Portugal.
Simonova M; Department of Gastroenterology, HPB and Transplant Surgery, Military Medical Academy, Sofia, Bulgaria.
Dalgard O; Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway.
Dahl EH; Department of Medicine, Haukeland University Hospital, Bergen, Norway.
de Martel C; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France.
Mozalevskis A; World Health Organization Regional Office for Europe, Copenhagen, Denmark.
Buti M; Liver Unit, Hospital General Universitario Vall d'Hebron and CIBEREHD del Instituto Carlos III., Barcelona, España.
Pavlova S; Department of Gastroenterology, HPB and Transplant Surgery, Military Medical Academy, Sofia, Bulgaria.
Hadzhilova T; Department of Gastroenterology, HPB and Transplant Surgery, Military Medical Academy, Sofia, Bulgaria.
Simões C; Laboratório de Nutrição, Faculdade de Medicina, Clínica Universitária de Gastrenterologia, Universidade de Lisboa, Lisboa, Portugal.
Katzarov K; Department of Gastroenterology, HPB and Transplant Surgery, Military Medical Academy, Sofia, Bulgaria.
Mardh O; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2021 Aug; Vol. 28 (8), pp. 1177-1189. Date of Electronic Publication: 2021 Jun 08.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/epidemiology
Hepatitis B*/complications
Hepatitis B*/epidemiology
Liver Neoplasms*/epidemiology
Humans ; Liver Cirrhosis/complications ; Liver Cirrhosis/epidemiology ; Pilot Projects
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies